LILRB3 suppresses immunity in glioma and is associated with poor prognosis

LILRB3 suppresses immunity in glioma and is associated with poor prognosis

Bibliographic Details
Main Authors:	Qiyuan Zhuang, Ying Liu, Hanze Wang, Ziyang Lin, Li Sun, Yue Liu, Yingying Lyu, Liang Chen, Hui Yang, Ying Mao
Format:	Article
Language:	English
Published:	Wiley 2023-10-01
Series:	Clinical and Translational Medicine
Online Access:	https://doi.org/10.1002/ctm2.1396

Similar Items

Elevated LILRB1 expression predicts poor prognosis and is associated with tumor immune infiltration in patients with glioma
by: Renheng Zou, et al.
Published: (2023-05-01)

PROS1 shapes the immune-suppressive tumor microenvironment and predicts poor prognosis in glioma
by: Jinxiang Wang, et al.
Published: (2023-01-01)

Identification of RP11‐770J1.4 as immune‐related lncRNA regulating the CTXN1–cGAS–STING axis in histologically lower‐grade glioma
by: Qiyuan Zhuang, et al.
Published: (2023-12-01)

High LYRM4-AS1 predicts poor prognosis in patients with glioma and correlates with immune infiltration
by: Hai yue Wang, et al.
Published: (2023-10-01)

LILRB4, an immune checkpoint on myeloid cells
by: Ting Yang, et al.
Published: (2022-04-01)

Molecular regulatory mechanism of LILRB4 in the immune response
by: Haiyin Liu, et al.
Published: (2023-02-01)

TREM2 is associated with tumor immunity and implies poor prognosis in glioma
by: Mingchen Yu, et al.
Published: (2023-01-01)

High expression of PCOLCE gene indicate poor prognosis in patients and are associated with immune infiltration in glioma
by: Qingbao Guo, et al.
Published: (2023-03-01)

MAPK-activated protein kinase 2 is associated with poor prognosis of glioma patients and immune inhibition in glioma
by: Jinmin Sun, et al.
Published: (2024-01-01)

The Tropomyosin Family as Novel Biomarkers in Relation to Poor Prognosis in Glioma
by: Ke Huang, et al.
Published: (2022-07-01)

PLEKHA4 is Associated with Tumour Microenvironment, Stemness, Proliferation and Poor Prognosis of Gliomas
by: Xin Gao, et al.
Published: (2023-08-01)

MAPK9 is Correlated with a Poor Prognosis and Tumor Progression in Glioma
by: Xinyu Yang, et al.
Published: (2023-03-01)

Dysregulation of LINC00324 promotes poor prognosis in patients with glioma.
by: Xin Jin, et al.
Published: (2024-01-01)

Dysregulation of LINC00324 promotes poor prognosis in patients with glioma
by: Xin Jin, et al.
Published: (2024-01-01)

Abnormal expression of HOXD11 promotes the malignant behavior of glioma cells and leads to poor prognosis of glioma patients
by: Jialin Wang, et al.
Published: (2021-02-01)

MHC1/LILRB1 axis as an innate immune checkpoint for cancer therapy
by: Ziyi Hu, et al.
Published: (2024-06-01)

Perspectives of targeting LILRB1 in innate and adaptive immune checkpoint therapy of cancer
by: Tobias Zeller, et al.
Published: (2023-09-01)

519 OR641 is a novel dual antagonist antibody that targets LILRB1 and LILRB2 inhibitory receptors and promotes a Th1-like immune response
by: Peter Probst, et al.
Published: (2023-11-01)

575 Preclinical characterization of LAE111, a potent anti-LILRB1/LILRB2 antagonist bispecific antibody
by: Rong Wu, et al.
Published: (2023-11-01)

Nuclear translocation of nucleotide enzyme Phosphoglucomutase 2 governs DNA damage response and anti-tumor immunity
by: Yingying Lyu, et al.
Published: (2024-09-01)

The involvement of brain regions associated with lower KPS and shorter survival time predicts a poor prognosis in glioma
by: Hongbo Bao, et al.
Published: (2023-12-01)

The LILRB family in hematologic malignancies: prognostic associations, mechanistic considerations, and therapeutic implications
by: Alan Hodges, et al.
Published: (2024-12-01)

DSN1 may predict poor prognosis of lower-grade glioma patients and be a potential target for immunotherapy
by: Yulong Jia, et al.
Published: (2024-12-01)

High expression of COPZ2 is associated with poor prognosis and cancer progression in glioma
by: Zhi Geng, et al.
Published: (2024-07-01)

WD repeat domain 76 predicts poor prognosis in lower grade glioma and provides an original target for immunotherapy
by: Xingbo Cheng, et al.
Published: (2024-01-01)

Disease-specific suppressive granulocytes participate in glioma progression
by: Jiarui Zhao, et al.
Published: (2024-12-01)

Analysis of cuproptosis-related genes in prognosis and immune infiltration in grade 4 diffuse gliomas
by: Hui Liu, et al.
Published: (2024-04-01)

Prevalence of and prognosis for poor immunological recovery by virally suppressed and aged HIV-infected patients
by: Lina Fan, et al.
Published: (2023-10-01)

1356 DM926, a novel anti-LILRB1/LILRB2 dual antagonist antibody, promotes adaptive and innate immune response to enhance anti-tumor activity in preclinical models
by: Yi Xu, et al.
Published: (2023-11-01)

LILRB2/PirB mediates macrophage recruitment in fibrogenesis of nonalcoholic steatohepatitis
by: Dan-Pei Li, et al.
Published: (2023-07-01)

CLEC7A regulates M2 macrophages to suppress the immune microenvironment and implies poorer prognosis of glioma
by: Jinchao Wang, et al.
Published: (2024-05-01)

Elevated SLC3A2 associated with poor prognosis and enhanced malignancy in gliomas
by: Yuheng Xu, et al.
Published: (2024-07-01)

Proteomic profiling of gliomas unveils immune and metabolism-driven subtypes with implications for anti-nucleotide metabolism therapy
by: Jinsen Zhang, et al.
Published: (2024-11-01)

LILRB4 represents a promising target for immunotherapy by dual targeting tumor cells and myeloid-derived suppressive cells in multiple myeloma
by: Lixin Gong, et al.
Published: (2024-05-01)

Structural basis for RIFIN-mediated activation of LILRB1 in malaria
by: Harrison, TE, et al.
Published: (2020)

LILRB4 Checkpoint for Immunotherapy: Structure, Mechanism and Disease Targets
by: Zhiqing Xiang, et al.
Published: (2024-02-01)

Bone Metastasis Mediates Poor Prognosis in Early‐Onset Gastric Cancer: Insights Into Immune Suppression, Coagulopathy, and Inflammation
by: Shi Yin, et al.
Published: (2025-03-01)

High expression of stromal signatures correlated with macrophage infiltration, angiogenesis and poor prognosis in glioma microenvironment
by: Yixin Tian, et al.
Published: (2020-05-01)

DKK3 expression is associated with immunosuppression and poor prognosis in glioblastoma, in contrast to lower-grade gliomas
by: Myung-Hoon Han, et al.
Published: (2023-05-01)

The Ion Channel Gene KCNAB2 Is Associated with Poor Prognosis and Loss of Immune Infiltration in Lung Adenocarcinoma
by: Yin Lyu, et al.
Published: (2022-10-01)